{"transactions":[{"id":700300,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":27622,"kind":"person","name":"Williamson Douglas J","position":1,"cik":"0001911501","reported_name":"Williamson Douglas J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-07-31T12:56:25.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":40826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant."}],"balance_after":40826,"derivative":{"exercise_price":0.2433,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":40826},"source":{"system":"sec-edgar","filing":"0001911501-26-000006","document":"form4-07312026_120720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1911501/000191150126000006/form4-07312026_120720.xml","form_type":"4"}},{"id":2020968,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27622,"kind":"person","name":"Williamson Douglas J","position":1,"cik":"0001911501","reported_name":"Williamson Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Research & Dev"}}],"security":"Restricted Stock Units","published_at":"2023-02-13T23:45:02.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":50655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is subject to the 2023 Inducement Plan and represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the shares subject to the restricted stock units vest on the second anniversary of February 10, 2023, with the balance vesting in two equal annual installments thereafter, such that the shares subject to the restricted stock units will be fully vested on the fourth anniversary of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the shares subject to the restricted stock units vest on the second anniversary of February 10, 2023, with the balance vesting in two equal annual installments thereafter, such that the shares subject to the restricted stock units will be fully vested on the fourth anniversary of such date."}],"balance_after":50655,"derivative":{"underlying":"Common Stock","underlying_shares":50655},"source":{"system":"sec-edgar","filing":"0001209191-23-008875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1911501/000120919123008875/doc4.xml","form_type":"4"}},{"id":2020967,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":27622,"kind":"person","name":"Williamson Douglas J","position":1,"cik":"0001911501","reported_name":"Williamson Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Research & Dev"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-02-13T23:45:02.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":237296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest on the first anniversary of February 10, 2023, with the balance vesting in 36 equal monthly installments thereafter, such that the shares subject to the option will be fully vested on the fourth anniversary of such date."}],"balance_after":237296,"derivative":{"exercise_price":18.97,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":237296},"source":{"system":"sec-edgar","filing":"0001209191-23-008875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1911501/000120919123008875/doc4.xml","form_type":"4"}},{"id":2393224,"issuer":{"id":65991,"kind":"organization","name":"AVADEL PHARMACEUTICALS PLC","symbol":"AVDL"},"owners":[{"id":27622,"kind":"person","name":"Williamson Douglas J","position":1,"cik":"0001911501","reported_name":"Williamson Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-16T21:40:17.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options become exercisable as to 68,750 ADSs on each of the first four anniversaries after the 2/14/2022 grant date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The issuer's \"ADSs\" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts."}],"balance_after":275000,"derivative":{"exercise_price":6.6,"expiration_date":"2032-02-14","underlying":"ADSs","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001179110-22-001332","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1911501/000117911022001332/edgar.xml","form_type":"4"}}]}